@Jimmy I was just mulling over the same question on my run this morning.

It is being actively recommended by some brokers and fund managers at the moment on the strength of DAYBUE sales strong start in the US.

In addition, NNZ-2591 is coming into focus with 4 parallel CTs under way, and the initial Phase 2 readout for the PMS CT due any day now. So it’s possible there is some speculative positioning going on ahead of that. If the soundings are positive, it should represent the next material leg up.